TY - JOUR
TI - Can initial hematocrit predict blood transfusions, hospital cost, and mortality in polytrauma patients?
AU - Petroudi, D.
AU - Tsagkaris, I.
AU - Mastrokalos, D.
AU - Papagelopoulos, P.
AU - Kontogeorgakos, V.
JO - Journal of Long-Term Effects of Medical Implants
PY - 2020
VL - 30
TODO - 2
SP - 83-86
PB - Begell House, Inc
SN - 1050-6934
TODO - 10.1615/JLongTermEffMedImplants.2020035548
TODO - Hospitals, Blood transfusion;  Hospital costs;  Polytrauma;  Standard deviation, Dielectric devices, adult;  aged;  Article;  blood transfusion;  female;  hematocrit;  hospital cost;  hospitalization;  human;  intensive care unit;  major clinical study;  male;  mortality;  mortality rate;  multiple trauma;  patient;  blood transfusion;  erythrocyte transfusion;  hematocrit;  multiple trauma;  retrospective study, Blood Transfusion;  Erythrocyte Transfusion;  Female;  Hematocrit;  Hospital Costs;  Humans;  Multiple Trauma;  Retrospective Studies
TODO - Knowing the initial hematocrit of a polytrauma patient can assist his trauma management. This paper describes a four-year study of 88 polytrauma patients. Fifty-nine were transfused, and eight were women (13.5%). The mean cost of the first hospitalization of patients who were transfused was 14,503 €; the mean cost of patients who were not transfused was 5,718 €. HCT did not correlate with ICU stay; nor did days of hospitalization. The mean HCT of those who died was not much different from that of survivors (33.23 with standard deviation [SD] 7.43 versus 32.37 with SD 5.89). This study showed that initial HCT does not correlate with days of hospitalization or days in ICU, but that transfusion can predict higher total cost. © 2020 by Begell House, Inc. www.begellhouse.com.
ER -